Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 5394-23-0 Chemical Structure| 5394-23-0

Structure of 5394-23-0

Chemical Structure| 5394-23-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 5394-23-0 ]

CAS No. :5394-23-0
Formula : C12H6Cl2N2
M.W : 249.10
SMILES Code : ClC1=C(C=CC2=C(Cl)C=CN=C32)C3=NC=C1
MDL No. :MFCD00233882
InChI Key :GIEQBYJCGYHHSU-UHFFFAOYSA-N
Pubchem ID :219391

Safety of [ 5394-23-0 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H315-H318-H335
Precautionary Statements:P261-P280-P301+P310-P305+P351+P338
Class:8(6.1)
UN#:2923
Packing Group:

Computational Chemistry of [ 5394-23-0 ] Show Less

Physicochemical Properties

Num. heavy atoms 16
Num. arom. heavy atoms 14
Fraction Csp3 0.0
Num. rotatable bonds 0
Num. H-bond acceptors 2.0
Num. H-bond donors 0.0
Molar Refractivity 67.06
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

25.78 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.24
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

3.71
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

4.09
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.94
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

4.19
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

3.43

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-4.37
Solubility 0.0106 mg/ml ; 0.0000427 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.94
Solubility 0.0284 mg/ml ; 0.000114 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-6.24
Solubility 0.000143 mg/ml ; 0.000000574 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Poorly soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

Yes
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

Yes
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.19 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<2.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.55

Application In Synthesis of [ 5394-23-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 5394-23-0 ]

[ 5394-23-0 ] Synthesis Path-Downstream   1~54

  • 5
  • [ 106-44-5 ]
  • [ 5394-23-0 ]
  • [ 156492-31-8 ]
  • 6
  • [ 5394-23-0 ]
  • [ 111-86-4 ]
  • 4,7-dioctylamino-1,10-phenanthroline [ No CAS ]
  • 7
  • [ 5394-23-0 ]
  • [ 90-15-3 ]
  • [ 156492-34-1 ]
  • 8
  • [ 5394-23-0 ]
  • [ 98-54-4 ]
  • [ 156492-32-9 ]
  • 9
  • [ 5394-23-0 ]
  • [ 150-76-5 ]
  • [ 156492-33-0 ]
  • 12
  • [ 5394-23-0 ]
  • [ 109-77-3 ]
  • [ 81315-61-9 ]
  • 13
  • [ 5394-23-0 ]
  • [ 100-51-6 ]
  • [ 111301-95-2 ]
  • 16
  • [ 110-89-4 ]
  • [ 5394-23-0 ]
  • [ 58712-30-4 ]
YieldReaction ConditionsOperation in experiment
93.5% at 80℃; for 12h;Inert atmosphere; Sealed tube; High pressure; In this example, under the protection of nitrogen, A-37-1 (1.0g, 4.0mmol) and A-37-2 (20ml) were added to a 50ml thick-walled pressure bottle, and the tube was sealed and heated to 80C for 12 hours. After cooling, distillation under reduced pressure gave the final product A-37 (1.3 g, 93.5% yield, HPLC analysis purity 99.4%) as a white solid
  • 17
  • [ 5394-23-0 ]
  • [ 75-33-2 ]
  • [ 168206-32-4 ]
  • 18
  • [ 5394-23-0 ]
  • [ 106-45-6 ]
  • [ 168206-33-5 ]
  • 25
  • [ 95-54-5 ]
  • pyridine-dicarboxylic acid-(2.3)-2-ethyl ester [ No CAS ]
  • [ 5394-23-0 ]
  • 26
  • [ 5394-23-0 ]
  • 4,7-(epoxy<1,4>-benzenoxyethanoxyethanoxy<1,4>-benzenoxy)-1,10-phenanthroline [ No CAS ]
  • 27
  • [ 5394-23-0 ]
  • 4,7-(epoxy<1,4>-benzenoxyethanoxyethanoxyethanoxy<1,4>-benzenoxy)-1,10-phenanthroline [ No CAS ]
  • 29
  • [ 5394-23-0 ]
  • 4,7-(epoxy<1,4>-benzenoxyethanoxyethanoxyethanoxyethanoxyethanoxy<1,4>-benzenoxy)-1,10-phenanthroline [ No CAS ]
  • 35
  • [ 5394-23-0 ]
  • [ 17029-22-0 ]
  • dichlorobis(1,10-phenanthroline)ruthenium(II) dihydrate [ No CAS ]
  • [ 92543-38-9 ]
  • 36
  • [ 5394-23-0 ]
  • tetrakis(acetonitrile)palladium bistriflate [ No CAS ]
  • Pd(C12H6N2Cl2)2(2+)*2CF3SO3(1-)=[Pd(C12H6N2Cl2)2](OSO2CF3)2 [ No CAS ]
  • 37
  • [ 5394-23-0 ]
  • [ 21797-13-7 ]
  • Pd(C12H6N2Cl2)2(2+)*2BF4(1-)=[Pd(C12H6N2Cl2)2](BF4)2 [ No CAS ]
  • 40
  • [ 5394-23-0 ]
  • [ 108-00-9 ]
  • [ 1204587-48-3 ]
  • 41
  • [ 5394-23-0 ]
  • [ 110-60-1 ]
  • [ 1204587-47-2 ]
  • 42
  • [ 5394-23-0 ]
  • [ 3529-10-0 ]
  • [ 1204587-49-4 ]
  • 43
  • [ 5394-23-0 ]
  • [ 14814-09-6 ]
  • [ 1256157-70-6 ]
  • 44
  • [ 5394-23-0 ]
  • [ 402-43-7 ]
  • [ 1349174-59-9 ]
  • 45
  • [ 5394-23-0 ]
  • [ 201802-67-7 ]
  • [ 1233221-54-9 ]
YieldReaction ConditionsOperation in experiment
With potassium phosphate;tris-(dibenzylideneacetone)dipalladium(0); tricyclohexylphosphine; In 1,4-dioxane; water; at 80 - 100℃;Inert atmosphere; Example 10; This example illustrates the preparation of phenanthroline derivative Compound 14, using Suzuki coupling of <strong>[5394-23-0]4,7-dichloro-1,10-phenanthroline</strong> with the boronic ester shown below. Take 2.0 g of dichloro-phen (8 mM) in glove box and add 4.7 g (17 mM) boronic acid. Add 0.15 g Pd2 DBA3 (0.15 mM), 0.1 g tricyclohexylphosphine (0.35 mM) and 3.75 g potassium phosphate (17 mM) and dissolve all into 30 mL dioxane and 15 mL water. Mix and heat in glove box in mantle at 100 C for 1 hr then warm gently (minimum rheostat setting) under nitrogen overnight. Solution immediately is dark purple but on reaching 80 C it is a tan brown slurry which slowly becomes clear brown. As the solution refluxes (air condensor) it remains clear brown. Cool and work up by removing from glove box and evaporate out the dioxane then add more water. Filter off light brown gummy solid and wash with water. Solid dissolves well in toluene and DCM. The structure was confirmed by NMR analysis to be Compound 14:
  • 46
  • [ 5394-23-0 ]
  • [ 870774-25-7 ]
  • [ 1233221-58-3 ]
YieldReaction ConditionsOperation in experiment
89% With potassium phosphate;tris-(dibenzylideneacetone)dipalladium(0); tricyclohexylphosphine; In 1,4-dioxane; water;Reflux; Example 14; This example illustrates the preparation of phenanthroline derivative Compound 19.To 4,7-dichlorophenanthroline (1.245 g, 0.0050 mol) and the 3-boronate ester of triphenylamine (4.1 g, 0.0111 mol), Pd2/DBA3 (0.3 g) and tricyclohexyl phosphine (0.21 g) in 30 ml 1,4-dioxane was added followed by 4.75 g K3PO4 in 15 ml of water and refluxed overnight. Cooled and performed water/Chloroform extraction of mixture. recrystallized from DCM/hexanes, then silica chromatography using CHCl3/MeOH concentrated heart cuts almost all the way and filtered for 1.6 grams Yield is 89%. The structure was confirmed by NMR analysis to be Compound 19:
  • 47
  • [ 5394-23-0 ]
  • [ 870119-58-7 ]
  • [ 1233221-55-0 ]
YieldReaction ConditionsOperation in experiment
With potassium phosphate;tris-(dibenzylideneacetone)dipalladium(0); tricyclohexylphosphine; In 1,4-dioxane; water; at 80 - 100℃;Inert atmosphere; Example 11; This example illustrates the preparation of phenanthroline derivative Compound 15, using Suzuki coupling of 4,7-dichloro-1,10-phenanthroline with the boronic ester shown below. Take 2.5 g of dichloro-phen (10 mM) in glove box and add 8.0 g (22 mM) boronic ester. Add 0.30 g Pd2 DBA3 (0.30 mM), 0.2 g tricylcohexylphosphine (0.70 mM) and 7.5 g potassium phosphate (34 mM) and dissolve all into 60 mL dioxane and 30 mL water. Mix and heat in glove box in mantle at 100 C for 1 hr then warm gently (minimum rheostat setting) under nitrogen overnight. Solution immediately is dark purple but on reaching 80 C it is a tan brown slurry which slowly becomes clear brown. As the solution refluxes (air condensor) no ppt forms. Cool and work up by removing from glove box and filter off orange gum from the dioxane after adding more water (on celite). Dissolve into chloroform and then chromatograph on column of silica/florisil/alumina (B) and elute with DCM (elutes blue PL fraction in very low amount as a pale yellow solution). Change to 50:50 methanol/DCM and elute orange solution which appears to be bulk of the material. Product seems to be extremely soluble but ?crystallizes? as a white powder from acetone/methanol/DCM mixture. Recover 5.6 g of white product sent for nmr in DCM (colorless solution with blue PL). The structure was confirmed by NMR analysis as Compound 15:
  • 48
  • [ 5394-23-0 ]
  • [ 943899-12-5 ]
  • [ 1233221-59-4 ]
YieldReaction ConditionsOperation in experiment
67% With potassium phosphate;tris-(dibenzylideneacetone)dipalladium(0); tricyclohexylphosphine; In 1,4-dioxane; water;Reflux; Example 15; This example illustrates the preparation of phenanthroline derivative Compound 20.To <strong>[5394-23-0]4,7-dichlorophenanthroline</strong> (1.245 g, 0.0050 mol), and 4-(1-naphthyl)phenylboronic acid (5.5 g, 0.0111 mol), Pd2/DBA3 (0.3 g) and tricyclohexyl phosphine (0.21 g) in 30 ml 1,4-dioxane was added followed by 4.75 g K3PO4 in 15 ml of water and refluxed overnight. Cooled and performed water/DCM extraction of mixture. Major fractions were recrystallized from DCM and methanol then filtered and dried to 2.23 g, 67% yield. The structure was confirmed by NMR analysis to be Compound 20:
  • 49
  • [ 5394-23-0 ]
  • [ 536-74-3 ]
  • [ 192226-55-4 ]
  • 50
  • [ 5394-23-0 ]
  • [ 89343-06-6 ]
  • [ 1414364-60-5 ]
YieldReaction ConditionsOperation in experiment
78% Experimental Details. 0.30 g (1.2 mmol) of <strong>[5394-23-0]4,7-dichloro-1,10-phenanthroline</strong>, 0.27 g (2.2 eq.) of phenylacetylene, 0.05 g(0.05 eq.) of (dppf)PdCl2n CH2Cl2, 0.24 g (2 eq.) of triethylamine,and 0.14 g (0.6 eq.) of copper iodide were suspended in 10 mL ofbenzene. This suspension was refluxed for 72 h under argon.10 mL of a 10% aqueous KCN solution and 10 mL dichloromethane were then added and the resulting mixture was stirred for 30 min at room temperature. The organic layer was extracted with 50 mLof dichloromethane twice and washed with water three times. The solvent was then evaporated and the solid was purified by alumina column chromatography (dichloromethane and gradient with methanol; the middle of the three bands is the desired product)to obtain an ivory solid (compound 1, 0.36 g, 78%). 1H NMR(300 MHz, CDCl3): 9.18(d, J = 4.5 Hz, 2H), 8.48(s, 2H), 7.80(d,J = 4.5 Hz, 2H), 7.70(m, 4H), 7.45(m, 6H). 13C NMR (75 MHz, CDCl3):149.83, 146.27, 131.98, 129.96, 129.51, 128.64, 128.37, 125.47,125.02, 122.10, 99.21, 85.04. MS: 380.6(M, 100%).
  • 51
  • [ 123-75-1 ]
  • [ 5394-23-0 ]
  • [ 1422577-91-0 ]
YieldReaction ConditionsOperation in experiment
80% With sodium hydride; In tetrahydrofuran; for 12h;Inert atmosphere; Reflux; In this example, under the protection of nitrogen, A-5-1 (1.0g, 4.0mmol), A-5-2 (0.9g, 12.0mmol, 3.0equiv.) were added to a 50ml round-bottomed flask with tetrahydrofuran (20ml) As a solvent, sodium hydride (0.2g) was added, heated to reflux for 12 hours, cooled, filtered, and concentrated in vacuo. The final product A-5 (1.0 g, 80% yield, HPLC analysis purity 99.5%) was obtained by column chromatography as a white solid.
  • 52
  • potassium cyanide [ No CAS ]
  • [ 5394-23-0 ]
  • [ 536-74-3 ]
  • [ 192226-55-4 ]
  • 53
  • [ 557-21-1 ]
  • [ 5394-23-0 ]
  • [ 1228826-15-0 ]
YieldReaction ConditionsOperation in experiment
60% With 1,1'-bis-(diphenylphosphino)ferrocene; bis(dibenzylideneacetone)-palladium(0); zinc; In N,N-dimethyl-formamide; at 130℃; for 1h;Inert atmosphere; Microwave irradiation; General procedure: (Microwave Conditions): A mixture of 4-chloro-1,10-phenanthroline (66mg, 0.31mmol), Zn(CN)2 (35mg, 0.3mmol), [Pd(dba)2] (3.6mg, 2mol%), Zn powder (2.0mg, 10mol%) and dppf (3.5mg, 2mol%) was heated with 5mL dried and degassed DMF in an argon-flushed and sealed microwave vial to 130C for 1h with a heating power of 200W. Purification was similar in terms of the thermal conditions. Yield: 49mg (70%).
  • 54
  • [ 5394-23-0 ]
  • [ 74-89-5 ]
  • [ 92193-03-8 ]
 

Historical Records

Technical Information

Categories